“SGLT2 Inhibitor Safety Signals in FAERS Ketoacidosis and Other Adverse Events across 154,476 Spontaneous Reports”. 2026. Diabzen 4 (16): 32-33. https://thediabzen.com/index.php/d/article/view/59.